DCF — PHOEBE SUMTER MEDICAL CENTER INC.
Enterprise Value: $-41.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-41.9M
Enterprise Value
$-15.9M
PV of Cash Flows
$-26.0M
PV of Terminal Value
$-41.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $104.0M | $-1.2M | -1.0% | $-5.6M | $-5.1M |
| Year 2 | $107.1M | $-0.1M | -0.0% | $-4.7M | $-3.9M |
| Year 3 | $110.3M | $1.0M | 1.0% | $-3.7M | $-2.8M |
| Year 4 | $113.6M | $1.5M | 1.0% | $-3.3M | $-2.2M |
| Year 5 | $117.0M | $1.9M | 2.0% | $-3.1M | $-1.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-41.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$101.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.01637642368693339
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5